{"id":37489,"date":"2026-02-18T17:33:12","date_gmt":"2026-02-18T16:33:12","guid":{"rendered":"https:\/\/mabdesign.fr\/?p=37489"},"modified":"2026-03-03T11:04:51","modified_gmt":"2026-03-03T10:04:51","slug":"therapeutic-antibodies","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/","title":{"rendered":"Therapeutic antibodies"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"37489\" class=\"elementor elementor-37489 elementor-37482\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7fc1a69 e-flex e-con-boxed e-con e-parent\" data-id=\"7fc1a69\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7a0ec25 elementor-widget elementor-widget-text-editor\" data-id=\"7a0ec25\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>MabDesign\u2019s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of therapeutic antibodies.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-ce4a3b7 e-flex e-con-boxed e-con e-parent\" data-id=\"ce4a3b7\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-aa7126d elementor-widget elementor-widget-text-editor\" data-id=\"aa7126d\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"text-decoration: underline;\"><strong>Market &amp; pipeline analysis<\/strong><\/span><\/p><p>Over the past decades, therapeutic antibodies have progressively established themselves as a major class of biopharmaceutical products. Initially dominated by monoclonal antibodies, the field has expanded to include a growing diversity of formats, reflecting advances in antibody engineering and a deeper understanding of disease biology.<\/p><p>In 2024, the global therapeutic antibody market reached <strong>USD 272 billion<\/strong>. Between 2024 and 2031, the market is expected to grow at a <strong>compound annual growth rate (CAGR) of 9.4%<\/strong>, confirming the sustained momentum of antibody-based therapies across multiple therapeutic areas.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b1391ef e-flex e-con-boxed e-con e-parent\" data-id=\"b1391ef\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8980e5f elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"8980e5f\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Key figures<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-372d777 e-flex e-con-boxed e-con e-parent\" data-id=\"372d777\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-efca734 e-con-full e-flex e-con e-child\" data-id=\"efca734\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t<div class=\"elementor-element elementor-element-2f198e2 e-con-full e-flex e-con e-child\" data-id=\"2f198e2\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t<div class=\"elementor-element elementor-element-6532b9c e-con-full e-flex e-con e-child\" data-id=\"6532b9c\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a03802e elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"a03802e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h1>272 <strong>billion<\/strong><strong>\u00a0 $<\/strong><\/h1>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-19dc9ce elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"19dc9ce\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Market size (2024) <\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-e5b2331 e-con-full e-flex e-con e-child\" data-id=\"e5b2331\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2216055 elementor-widget elementor-widget-text-editor\" data-id=\"2216055\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h1>9,4%<\/h1>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-abeae30 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"abeae30\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>CAGR (2024\u20132031)<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3209f72 e-con-full e-flex e-con e-child\" data-id=\"3209f72\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e6a37b0 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"e6a37b0\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h1><strong>675<\/strong><\/h1>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-457c2f8 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"457c2f8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Marketed therapeutic antibodies :<\/strong><\/p><p>(all formats)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-eb254ea e-con-full e-flex e-con e-child\" data-id=\"eb254ea\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a62c9d6 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"a62c9d6\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h1><strong>66%<\/strong><\/h1>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-dce0c1c elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"dce0c1c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Share of monoclonal antibodies:<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-915447b elementor-widget elementor-widget-text-editor\" data-id=\"915447b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>To date, <strong>675 therapeutic antibodies are marketed worldwide<\/strong>, across all antibody formats. Monoclonal antibodies represent the majority of marketed products, accounting for <strong>66%<\/strong> of therapeutic antibodies currently available on the market. This predominance reflects the maturity of monoclonal antibody platforms and their broad clinical use in oncology, immunology and inflammatory diseases.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0995882 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"0995882\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Current trends<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-02bb557 elementor-widget elementor-widget-text-editor\" data-id=\"02bb557\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Marketed antibodies<\/strong><\/p><p>Among therapeutic antibodies with marketing authorisation, <strong>monoclonal antibodies account for 58.1%<\/strong> of approved products. <strong>Polyclonal antibodies represent 32.1%<\/strong>, while more complex formats remain marginal at the marketed stage.<\/p><p><strong>Antibody fragments (3.4%)<\/strong>, <strong>multispecific antibodies (3.2%)<\/strong> and <strong>conjugated antibodies (3.2%)<\/strong> together account for a limited share of approved products, illustrating the higher technical and regulatory barriers associated with next-generation antibody formats.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4b0d53c e-con-full e-flex e-con e-child\" data-id=\"4b0d53c\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t<div class=\"elementor-element elementor-element-c655a25 e-con-full elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile e-flex e-con e-child\" data-id=\"c655a25\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8534b68 elementor-widget elementor-widget-text-editor\" data-id=\"8534b68\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>675<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a2f0b79 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"a2f0b79\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>anticorps th\u00e9rapeutiques sont commercialis\u00e9s dans le monde<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6ce8628 e-con-full e-flex e-con e-parent\" data-id=\"6ce8628\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t<div class=\"elementor-element elementor-element-8a3a791 e-con-full e-flex e-con e-child\" data-id=\"8a3a791\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-576c238 elementor-widget__width-initial elementor-widget elementor-widget-jet-pie-chart\" data-id=\"576c238\" data-element_type=\"widget\" data-widget_type=\"jet-pie-chart.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-jet-pie-chart jet-elements\"><div class=\"jet-pie-chart-title-container\"><h5 class=\"jet-pie-chart-title\">Marketed antibodies<\/h5><\/div>\n\t\t<div class=\"jet-pie-chart-container\" data-chart=\"{&quot;datasets&quot;:[{&quot;data&quot;:[58.1,32.1,3.4,3.2,3.2],&quot;backgroundColor&quot;:[&quot;#00B7BD&quot;,&quot;#43A49F&quot;,&quot;#017175&quot;,&quot;#013A43&quot;,&quot;#011013&quot;],&quot;borderWidth&quot;:1,&quot;borderColor&quot;:&quot;#ffffff&quot;,&quot;hoverBorderColor&quot;:&quot;#ffffff&quot;}],&quot;labels&quot;:[&quot;monoclonal antibodies &quot;,&quot;Polyclonal antibodies &quot;,&quot;Antibody fragments &quot;,&quot;multispecific antibodies&quot;,&quot;conjugated antibodies&quot;]}\" data-options=\"{&quot;animation&quot;:{&quot;duration&quot;:1000,&quot;easing&quot;:&quot;easeOutQuart&quot;,&quot;animateScale&quot;:false},&quot;legend&quot;:{&quot;display&quot;:true,&quot;position&quot;:&quot;right&quot;,&quot;reverse&quot;:false,&quot;align&quot;:&quot;center&quot;},&quot;tooltips&quot;:{&quot;enabled&quot;:true}}\" data-tooltip=\"%\">\n\t\t\t<canvas class=\"jet-pie-chart\" role=\"img\" aria-label=\"Marketed antibodies\"><\/canvas>\n\t\t<\/div>\n\n\t\t<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c6616fe elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"c6616fe\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u00a0<\/p><p>\u00a0Among therapeutic antibodies with marketing authorisation, <strong>monoclonal antibodies account for 58.1%<\/strong> of approved products. <strong>Polyclonal antibodies represent 32.1%<\/strong>, while more complex formats remain marginal at the marketed stage.<\/p><p><strong>Antibody fragments (3.4%)<\/strong>, <strong>multispecific antibodies (3.2%)<\/strong> and <strong>conjugated antibodies (3.2%)<\/strong> together account for a limited share of approved products, illustrating the higher technical and regulatory barriers associated with next-generation antibody formats.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-d77a2e4 e-con-full e-flex e-con e-child\" data-id=\"d77a2e4\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ac3e103 elementor-widget__width-initial elementor-widget elementor-widget-jet-pie-chart\" data-id=\"ac3e103\" data-element_type=\"widget\" data-widget_type=\"jet-pie-chart.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-jet-pie-chart jet-elements\"><div class=\"jet-pie-chart-title-container\"><h5 class=\"jet-pie-chart-title\">Antibodies in development (active pipeline)<\/h5><\/div>\n\t\t<div class=\"jet-pie-chart-container\" data-chart=\"{&quot;datasets&quot;:[{&quot;data&quot;:[35.9,19.8,16.9,14.8,12.5],&quot;backgroundColor&quot;:[&quot;#00B7BD&quot;,&quot;#00968F&quot;,&quot;#007377&quot;,&quot;#006272&quot;,&quot;#006272&quot;],&quot;borderWidth&quot;:1,&quot;borderColor&quot;:&quot;#ffffff&quot;,&quot;hoverBorderColor&quot;:&quot;#ffffff&quot;}],&quot;labels&quot;:[&quot;monoclonal antibodies &quot;,&quot;Polyclonal antibodies &quot;,&quot;multispecific antibodies &quot;,&quot;fragment antibodies &quot;,&quot; conjugated antibodies &quot;]}\" data-options=\"{&quot;animation&quot;:{&quot;duration&quot;:1000,&quot;easing&quot;:&quot;easeOutQuart&quot;,&quot;animateScale&quot;:false},&quot;legend&quot;:{&quot;display&quot;:true,&quot;position&quot;:&quot;right&quot;,&quot;reverse&quot;:false,&quot;align&quot;:&quot;center&quot;},&quot;tooltips&quot;:{&quot;enabled&quot;:true}}\" data-tooltip=\"%\">\n\t\t\t<canvas class=\"jet-pie-chart\" role=\"img\" aria-label=\"Antibodies in development (active pipeline)\"><\/canvas>\n\t\t<\/div>\n\n\t\t<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8406648 elementor-widget elementor-widget-text-editor\" data-id=\"8406648\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The composition of the <strong>active development pipeline<\/strong> highlights a more diversified landscape. While <strong>monoclonal antibodies remain the largest category (35.9%)<\/strong>, their relative weight is significantly lower than in the marketed portfolio.<\/p><p><strong>Polyclonal antibodies represent 19.8%<\/strong> of candidates in development, followed by <strong>multispecific antibodies (16.9%)<\/strong>, <strong>fragment antibodies (14.8%)<\/strong> and <strong>conjugated antibodies (12.5%)<\/strong>, including antibody\u2013drug conjugates (ADCs). This distribution reflects ongoing efforts to develop differentiated antibody formats with improved therapeutic profiles.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3bfe301 e-flex e-con-boxed e-con e-parent\" data-id=\"3bfe301\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-65f5186 elementor-widget elementor-widget-text-editor\" data-id=\"65f5186\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>European benchmark for antibody development<\/strong><\/p><p>Europe remains a key region for therapeutic antibody development. The <strong>United Kingdom, Switzerland and Germany<\/strong> are the leading European countries in terms of antibody development activity, with <strong>France positioned among the main contributors<\/strong>.<\/p><p>This European landscape reflects a combination of strong academic research, established industrial capabilities and structured innovation ecosystems supporting antibody development.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-152d5c8 e-flex e-con-boxed e-con e-parent\" data-id=\"152d5c8\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7dd2d03 elementor-widget elementor-widget-text-editor\" data-id=\"7dd2d03\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Focus on <\/strong><strong>Therapeutic antibodies in late-stage development<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-914f3c7 e-con-full e-flex e-con e-parent\" data-id=\"914f3c7\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-ac3546a elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"ac3546a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong>19 therapeutic antibodies<\/strong> currently in pre-registration<\/li><li><strong>4 candidates targeting psoriasis<\/strong>, highlighting the continued importance of immuno-inflammatory indications<\/li><li><strong>2 antibody\u2013drug conjugates (ADCs) developed in China<\/strong>, illustrating the growing contribution of Chinese players to late-stage antibody development<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a241600 elementor-widget__width-initial elementor-widget elementor-widget-jet-pie-chart\" data-id=\"a241600\" data-element_type=\"widget\" data-widget_type=\"jet-pie-chart.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-jet-pie-chart jet-elements\">\n\t\t<div class=\"jet-pie-chart-container\" data-chart=\"{&quot;datasets&quot;:[{&quot;data&quot;:[19,4,2],&quot;backgroundColor&quot;:[&quot;#00B7BD&quot;,&quot;#00968F&quot;,&quot;#007377&quot;],&quot;borderWidth&quot;:1,&quot;borderColor&quot;:&quot;#ffffff&quot;,&quot;hoverBorderColor&quot;:&quot;#ffffff&quot;}],&quot;labels&quot;:[&quot;therapeutic antibodies currently in pre-registration&quot;,&quot;candidates targeting psoriasis, highlighting the continued importance of immuno-inflammatory indications&quot;,&quot;antibody\\u2013drug conjugates (ADCs) developed in China&quot;]}\" data-options=\"{&quot;animation&quot;:{&quot;duration&quot;:1000,&quot;easing&quot;:&quot;easeOutQuart&quot;,&quot;animateScale&quot;:false},&quot;legend&quot;:{&quot;display&quot;:true,&quot;position&quot;:&quot;bottom&quot;,&quot;reverse&quot;:false,&quot;align&quot;:&quot;start&quot;},&quot;tooltips&quot;:{&quot;enabled&quot;:true}}\" data-tooltip=\"%\">\n\t\t\t<canvas class=\"jet-pie-chart\" role=\"img\"><\/canvas>\n\t\t<\/div>\n\n\t\t<div class=\"jet-pie-chart-title-container\"><h5 class=\"jet-pie-chart-title\"><\/h5><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-cf42057 e-flex e-con-boxed e-con e-parent\" data-id=\"cf42057\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8d3cb78 elementor-widget elementor-widget-text-editor\" data-id=\"8d3cb78\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Therapeutic antibodies represent a mature yet continuously evolving segment of the biopharmaceutical industry. While monoclonal antibodies continue to dominate the marketed landscape, the development pipeline points toward increasing diversification, with a growing number of multispecific, fragment and conjugated antibody candidates. These trends suggest a progressive evolution of the therapeutic antibody landscape in the years to come.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7f85e4e e-flex e-con-boxed e-con e-parent\" data-id=\"7f85e4e\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-1629280 e-con-full e-flex e-con e-child\" data-id=\"1629280\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-fe1af31 elementor-widget elementor-widget-heading\" data-id=\"fe1af31\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Download our infographic<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-67dfac7 elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile elementor-widget elementor-widget-heading\" data-id=\"67dfac7\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">projets de th\u00e9rapies bas\u00e9es sur l\u2019\u00e9dition du g\u00e9nome (gene-editing therapies) actuellement en d\u00e9veloppement. (2025)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7dbe063 elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"7dbe063\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"1024\" src=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb-768x1024.png\" class=\"attachment-large size-large wp-image-37484\" alt=\"\" srcset=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb-768x1024.png 768w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb-225x300.png 225w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb-1152x1536.png 1152w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png 1500w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cfd7c28 elementor-align-center elementor-widget__width-initial elementor-widget elementor-widget-button\" data-id=\"cfd7c28\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Download .PDF<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5b2916f e-con-full e-flex e-con e-child\" data-id=\"5b2916f\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8e2e2c5 elementor-widget elementor-widget-heading\" data-id=\"8e2e2c5\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Want to know more? <\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-45af870 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"45af870\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"text-align: justify;\">MabDesign has acquired and cultivated expertise in all market segments associated with biopharmaceuticals and biomanufacturing. Our team of consultants is available to assist you with all your biotherapy-related projects. Feel free to explore our range of services, including our marketing and strategic analyses, if you would like to learn more!<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1d5b9421 elementor-align-center elementor-widget__width-initial elementor-widget elementor-widget-button\" data-id=\"1d5b9421\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"mailto:services@mabdesign.fr?subject=Offre%20de%20services%20\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Contact us<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e1483b5 elementor-widget elementor-widget-text-editor\" data-id=\"e1483b5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Sources : MabDesign &amp; GlobalData<\/p><p><span style=\"text-align: var(--text-align); color: var( --e-global-color-text );\">Date &#8211; Ao\u00fbt 2025<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4308228 e-flex e-con-boxed e-con e-parent\" data-id=\"4308228\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>MabDesign\u2019s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of therapeutic antibodies.<\/p>\n","protected":false},"author":6,"featured_media":37484,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[88,119],"tags":[99,467,174,98,141,468],"class_list":["post-37489","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bio-hub-en","category-market-analysis-en","tag-antibodies","tag-anticorps-therapeutiques","tag-infectious-diseases","tag-innovation-en","tag-market","tag-therapeutiques"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Market Therapeutic antibodies - MabDesign<\/title>\n<meta name=\"description\" content=\"MabDesign\u2019s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of therapeutic antibodies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Market Therapeutic antibodies - MabDesign\" \/>\n<meta property=\"og:description\" content=\"MabDesign\u2019s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of therapeutic antibodies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-18T16:33:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T10:04:51+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"2000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Maissa Pote\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maissa Pote\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/\"},\"author\":{\"name\":\"Maissa Pote\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029\"},\"headline\":\"Therapeutic antibodies\",\"datePublished\":\"2026-02-18T16:33:12+00:00\",\"dateModified\":\"2026-03-03T10:04:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/\"},\"wordCount\":632,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png\",\"keywords\":[\"antibodies\",\"Anticorps th\u00e9rapeutiques\",\"infectious diseases\",\"innovation\",\"market\",\"th\u00e9rapeutiques\"],\"articleSection\":[\"Bio-hub\",\"Market analysis\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/\",\"name\":\"Market Therapeutic antibodies - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png\",\"datePublished\":\"2026-02-18T16:33:12+00:00\",\"dateModified\":\"2026-03-03T10:04:51+00:00\",\"description\":\"MabDesign\u2019s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of therapeutic antibodies.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png\",\"width\":1500,\"height\":2000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Therapeutic antibodies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029\",\"name\":\"Maissa Pote\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g\",\"caption\":\"Maissa Pote\"},\"url\":\"https:\/\/mabdesign.fr\/en\/author\/communication\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Market Therapeutic antibodies - MabDesign","description":"MabDesign\u2019s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of therapeutic antibodies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/","og_locale":"en_US","og_type":"article","og_title":"Market Therapeutic antibodies - MabDesign","og_description":"MabDesign\u2019s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of therapeutic antibodies.","og_url":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/","og_site_name":"MabDesign","article_published_time":"2026-02-18T16:33:12+00:00","article_modified_time":"2026-03-03T10:04:51+00:00","og_image":[{"width":1500,"height":2000,"url":"http:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png","type":"image\/png"}],"author":"Maissa Pote","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"Maissa Pote","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/"},"author":{"name":"Maissa Pote","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029"},"headline":"Therapeutic antibodies","datePublished":"2026-02-18T16:33:12+00:00","dateModified":"2026-03-03T10:04:51+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/"},"wordCount":632,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png","keywords":["antibodies","Anticorps th\u00e9rapeutiques","infectious diseases","innovation","market","th\u00e9rapeutiques"],"articleSection":["Bio-hub","Market analysis"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/","url":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/","name":"Market Therapeutic antibodies - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png","datePublished":"2026-02-18T16:33:12+00:00","dateModified":"2026-03-03T10:04:51+00:00","description":"MabDesign\u2019s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of therapeutic antibodies.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/02\/Feb.png","width":1500,"height":2000},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/therapeutic-antibodies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Therapeutic antibodies"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029","name":"Maissa Pote","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g","caption":"Maissa Pote"},"url":"https:\/\/mabdesign.fr\/en\/author\/communication\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/37489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=37489"}],"version-history":[{"count":29,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/37489\/revisions"}],"predecessor-version":[{"id":37748,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/37489\/revisions\/37748"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/37484"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=37489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=37489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=37489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}